Aesculap's 1995 sales rise 3.8%
This article was originally published in Clinica
Executive Summary
Despite difficult business conditions, Aesculap achieved a 3.8% rise in sales to DM 544.8 million ($390 million) during fiscal 1995 (ended September 30th). In the German company's home market, turnover increased 7.2% to DM 186.5 million, while Asia showed very healthy growth, up 11.2% to DM 81.5 million. Exchange rate effects caused US sales to fall 5.2% in Deutschmark terms, although expressed in dollars they grew 7.4%.